Is now the time to buy BD? Find out in our full research report. Adjusted EPS: $3.35 vs analyst estimates of $3.28 (2.1% beat) Adjusted EBITDA: $1.06 billion vs analyst estimates of $1.54 billion ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.35 in the second quarter of fiscal 2025, up 5.7% year over year. The figure topped the ...

Becton, Dickinson and Company BDX, popularly known as BD, is evaluating the divestment of its Life Sciences division as part of a broader strategic shift toward becoming a pure-play medtech company.